oral semaglutide approval A new class of GLP-1 that works differently than oral just got one step closer to FDA approval. Eli Lilly released new Phase 3 data on orforglipron. Swipe to learn FDA Approves First Oral Semaglutide

Mood Regulation: Lipo C injections keep liver disease at bay and regulate liver function

Both formulations are administered as intramuscular injections, usually weekly, as part of a medically-supervised weight loss protocol that includes caloric restriction and, increasingly, GLP-1 receptor agonist therapy like semaglutide or tirzepatide

This means you stay full longer, even with the smaller meal sizes common on GLP-1 medications

The mechanism is deceptively simple

Its antioxidants can lighten tanned skin and assure you of anti-ageing benefits, while Vitamin B, along with zinc, can help maintain healthy skin

References Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications | Health Affairs CMSs $40B GLP-1 Proposal Offers Leeway for Part D Plans to Define Obe AIS Health - MMIT Medicare & Medicaid Services CMS Proposes Changes to Medicare Adv Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know